May 2019 Member News

Member News provides an opportunity for SDEE members to share news and announcements. This month's Member News features:

  • Mark Fortner, Aspen Biosciences
  • Claire Weston, Reveal Biosciences
  • Stephane Richard, CureMatch
  • Grant Goad, WestSouth
  • Ray Wagenknecht, Wagenknecht IP Law Group
  • Sarah Glofcheskie, Axiom Real-Time Metrics
  • Francisco Lio, Neuropore
  • Michelleanne Bradley, Metis Consulting
  • Marilyn Bruno, Aequor

Mark Fortner, Aspen Biosciences

Software UpdatesWe're always looking for new features to add to Pharm2Market and this month we added:

  • Target-Based Searching-  making it easier to find local companies with experience and expertise in addressing specific drug targets. 
  • Activities Filtering- making it easier to see filter the growing list of database updates.
  • Improved Stat Chart Readability- making it easier to filter companies based on a variety of different statistics.
  • Getting Started Tutorial- making it easier for new users to explore some of the features and benefits of the Pharm2Market application. We also started working on video tutorials to make it even easier to get started.

In addition, we're working on an All Access Pass feature that will allow users to access data from all of our communities.

LaunchBio Demo - This month we partnered with LaunchBio at their Larger Than Life Science event. We demo'd Pharm2Market for drug discovery companies, CROs, consultants and investors; discussed the challenges that drug discovery startups face, and some strategies for addressing those challenges. We were really pleased with the response and feedback, and look forward to meeting and engaging with more members of the community.

Claire Weston, Reveal Biosciences

Hiring Summer Interns, please contact Claire [email protected]

Reveal Biosciences, Inc., a leader in pathology AI, has closed a Series A financing round led by Intel Capital with additional investment from the GNI Group and PP Capital. Reveal is focused on improving global healthcare by creating a new generation of objective, data-powered pathology to characterize and detect disease. Reveal’s pathology AI models generate quantitative data for preclinical research, clinical trials and patients. 

Stephane Richard, CureMatch

WeHealth by Servier, Servier Group’s e-health department, and CureMatch, a leader in digital health precision medicine announce a partnership to jointly bring the CureMatch digital platform to oncologists, clinics and hospitals around the world.

We’ve been working with oncologists closely the past few years and understand they face a daunting task of understanding the significance between thousands of genomic abnormalities and choosing between hundreds of drugs in order to match treatment options for their cancer patients. CureMatch’s digital platform has the opportunity to break through these barriers worldwide.

Grant Goad, WestSouth

West South is a new digital marketing agency in San Diego. We launched our company this year, and recently joined San Diego Entrepreneurs Exchange. We’re pleased to announce that we’re about to roll out our first projects—for Thermo Fisher Scientific and Carlsbad-based epigenetics company Active Motif.

We’re also dedicated to supporting the San Diego life sciences start-up community, and are about to wrap up a new website for our first client in the space, a local next-generation therapeutics company. Please take a moment to visit our website and let us know how we can help with your digital marketing needs: We look forward to meeting you!

Ray Wagenknecht, Wagenknecht IP Law Group

John Kaiser, started his career at Wagenknecht IP Law Group on May 15, 2017 as an Intellectual Property Summer Intern.  John went on to pass and became Wagenknecht’s official Patent Agent on February 25, 2019.  He will be graduating from University of San Diego’s School of Law on May 18, 2019, and has joined Wagenknecht IP Law Group full-time.

Antony Novom, Patent Attorney, with Wagenknecht IP Law Group has been named a 2019 Lawyer of Distinction.  Lawyers of Distinction are nominated and selected based upon a review and vetting process by its Selection Committee utilizing U.S. Provisional Patent # 62/743.254.  The platform generates a numerical score of 1 to 5 for each of the 12 enumerated factors which are meant to recognize the applicant’s achievements and peer recognition.  Members are then subject to a final review for ethical violations within the past ten years before confirmation of Membership. 

Sarah Glofcheskie, Axiom Real-Time Metrics

Axiom, premium provider of eClinical solutions and services is pleased to announce significant strategic growth funding via Great Point Partners, a leading healthcare investment firm with approximately $1.6 billion of equity capital currently under management. 
Axiom will utilize this investment to accelerate the development and addition of leading-edge elements to its Fusion eClinical platform as well as significantly expand its professional services and business development initiatives.

Francisco Lio, Neuropore

Neuropore introduces a 2nd drug into the clinic. Has an eye for Parkinson's disease and ALS.

Michelleanne Bradley, Metis Consulting

Metis Consulting Services is excited to announce that our website is now available in both English and Spanish, to better service our expanding domestic and international Spanish-speaking clientele.

Marilyn Bruno, Aequor

We have been invited to represent the United States at the Global Entrepreneurship Summit in The Hague – June 3-5 -  

We were recommended to the GES by NASA because Aequor's water treatments were the only non-toxic remedy for the contamination in the water recycling/reuse system used on board the ISS, solving the problems of life support and astronaut health. 


Be the first to comment

Or sign in with email

    Please check your e-mail for a link to activate your account.